Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Adaptive Symptom Self-Management Immunotherapy Study — Stella

Home/Breast Cancer/Adaptive Symptom Self-Management Immunotherapy Study

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer trials

Adaptive Symptom Self-Management Immunotherapy Study

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

United States

Valleywise Health Medical Center, Phoenix, Arizona

University of Arizona Cancer Center, Tucson, Arizona

University of Michigan, Ann Arbor, Michigan

Key details

Sponsor

University of Arizona

Collaborators

National Cancer Institute (NCI)

Enrollment target

~400 participants

Started

May 2023

Primary completion

April 2027

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.